"Receptors, Purinergic P1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).
| Descriptor ID |
D018047
|
| MeSH Number(s) |
D12.776.543.750.695.700.700 D12.776.543.750.720.700.700
|
| Concept/Terms |
Receptors, Purinergic P1- Receptors, Purinergic P1
- Adenosine Receptors
- Receptors, Adenosine
- P1 Purinoceptors
- Purinoceptors, P1
- Receptor, Purinergic P1
- P1 Receptor, Purinergic
- Purinergic P1 Receptor
- Purinergic P1 Receptors
- P1 Receptors, Purinergic
- Adenosine Receptor
- Receptor, Adenosine
- P1 Purinoceptor
- Purinoceptor, P1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic P1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic P1".
This graph shows the total number of publications written about "Receptors, Purinergic P1" by people in this website by year, and whether "Receptors, Purinergic P1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1997 | 2 | 1 | 3 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Purinergic P1" by people in Profiles.
-
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade. Cancer Discov. 2018 09; 8(9):1156-1175.
-
Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. J Neurosci. 2012 Oct 03; 32(40):13945-55.
-
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem. 2009 May 15; 284(20):13686-13695.
-
Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther. 2008 Aug; 22(4):275-82.
-
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1918-28.
-
Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism. J Pharmacol Exp Ther. 2003 Jun; 305(3):950-5.
-
Intrathecal adenosine following spinal nerve ligation in rat: short residence time in cerebrospinal fluid and no change in A(1) receptor binding. Anesthesiology. 2002 Jan; 96(1):103-8.
-
Evolutionary traces of functional surfaces along G protein signaling pathway. Methods Enzymol. 2002; 344:536-56.
-
Allosteric adenosine modulation to reduce allodynia. Anesthesiology. 2001 Aug; 95(2):416-20.
-
Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology. 1999 Oct; 91(4):1072-9.